Seamless Integration into Your Workflow
superRCA® MRD Assays can be easily integrated and processed with your existing lab infrastructure (no need for costly and specialized equipment).
- Easy to train and to perform
- Workflow consists of the serial addition of reagents to the same reaction well, followed by mixing and incubation
- Manual and automated processing options
| Manual Workflow | Automated Workflow |
| Can quickly be implemented within 1-2 days | Minimize hands-on time, with automation via Biomek i-Series liquid handlers with thermocycler integration |
 |
 |
 |
 |
Assay can be performed on DxFLEX* and CytoFLEX flow cytometers equipped with a plate loader module. DxFLEX Flow Cytometer with plate loader is for Research Use Only. Not for use in diagnostic procedures.
Integrate cellular and ultrasensitive molecular MRD detection by flow cytometry
Sensitivity matters! Especially in MRD research studies. superRCA® assays expand the capabilities of flow cytometry from classical immunophenotyping of hematological diseases to ultrasensitive molecular relapse discovery.
- Lower Limit of Detection (LoD) for Higher Sensitivity – Detects rare mutations at 1:100,000 sensitivity, surpassing NGS.
- Early molecular relapse detection – Identifies low-level disease persistence before visible disease relapse.
- Bridging flow cytometry and genotyping – Combines immunophenotyping and targeted genotyping for precise MRD research.
- Rapid results – Delivers fast and efficient MRD detection using standard flow cytometry.
MRD detection technologies according to purpose and course of the disease
